IMMUNOGEN
Live / Registered — Registered (as of 09 Jun 2020)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87831665
- Registration number
- 6075454
- Mark type
- Design + words
- Filed
- 13 Mar 2018
- Published for opposition
- 19 Feb 2019
- Registered
- 09 Jun 2020
- Attorney of record
- Jenevieve J. Maerker, Esq.
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of cancer; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Owner
- ImmunoGen, Inc., Waltham, MA, US
- ImmunoGen, Inc., Waltham, MA, US
- ImmunoGen, Inc., Waltham, MA, US
Prosecution history
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Apr 2020 — USE AMENDMENT FILED
- 29 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 03 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2019 — SOU EXTENSION 1 GRANTED
- 01 Oct 2019 — SOU EXTENSION 1 FILED
- 01 Oct 2019 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Feb 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Feb 2019 — PUBLISHED FOR OPPOSITION